应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01477 欧康维视生物-B
已收盘 07-28 16:09:12
9.390
+0.010
+0.11%
最高
9.500
最低
9.150
成交量
276.75万
今开
9.400
昨收
9.380
日振幅
3.73%
总市值
76.43亿
流通市值
76.43亿
总股本
8.14亿
成交额
2,583万
换手率
0.34%
流通股本
8.14亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
上海医药(02607.HK):硫酸沙丁胺醇注射液通过仿制药一致性评价
智通财经 · 10:06
上海医药(02607.HK):硫酸沙丁胺醇注射液通过仿制药一致性评价
歌礼制药-B盘中异动 下午盘股价大涨5.04%报11.260港元
市场透视 · 07:16
歌礼制药-B盘中异动 下午盘股价大涨5.04%报11.260港元
港股异动 | 中生制药(01177)再涨超6% 机构称BD交易有望成为公司的经常性收入和利润来源
智通财经 · 03:26
港股异动 | 中生制药(01177)再涨超6% 机构称BD交易有望成为公司的经常性收入和利润来源
和铂医药:预计上半年净利润6800万美元-7400万美元
格隆汇 · 00:50
和铂医药:预计上半年净利润6800万美元-7400万美元
歌礼制药-B(01672):小分子GLP-1R激动剂ASC30每月一次皮下储库型制剂的美国12周IIa期研究完成首批肥胖或超重受试者给药
智通财经 · 00:17
歌礼制药-B(01672):小分子GLP-1R激动剂ASC30每月一次皮下储库型制剂的美国12周IIa期研究完成首批肥胖或超重受试者给药
同道堂制药取得用于中药生产的结晶反应釜专利,可缩短重结晶时间
金融界 · 07-26 06:31
同道堂制药取得用于中药生产的结晶反应釜专利,可缩短重结晶时间
港股异动 | 和铂医药-B(02142)午后涨超8% 近期与大冢制药达成BD交易 公司上半年BD总额超66亿美元
智通财经 · 07-25
港股异动 | 和铂医药-B(02142)午后涨超8% 近期与大冢制药达成BD交易 公司上半年BD总额超66亿美元
港股异动 | 中生制药(01177.HK)再涨超4% 附属礼新医药LM-350获得美国FDA的IND批件
智通财经 · 07-25
港股异动 | 中生制药(01177.HK)再涨超4% 附属礼新医药LM-350获得美国FDA的IND批件
欧康维视生物-B07月24日主力净流入372.0万元 散户资金抛售
市场透视 · 07-24
欧康维视生物-B07月24日主力净流入372.0万元 散户资金抛售
制药企业将被转卖给大基金
动脉网 · 07-24
制药企业将被转卖给大基金
港股康希诺拉升涨近14%
格隆汇 · 07-24
港股康希诺拉升涨近14%
歌礼制药-B大涨5.32% 近日完成ASC47与司美格鲁肽联合使用的28例肥胖受试者给药
港美通 · 07-24
歌礼制药-B大涨5.32% 近日完成ASC47与司美格鲁肽联合使用的28例肥胖受试者给药
汉邦科技:公司作为制药装备生产提供商促进创新药发展
证券之星 · 07-23
汉邦科技:公司作为制药装备生产提供商促进创新药发展
莱美药业股价微涨0.20% 化学制药企业研发管线引关注
金融界 · 07-22
莱美药业股价微涨0.20% 化学制药企业研发管线引关注
7月22日AI制药(医疗)下跌0.58%,板块个股嘉和美康、润达医疗跌幅居前
金融界 · 07-22
7月22日AI制药(医疗)下跌0.58%,板块个股嘉和美康、润达医疗跌幅居前
歌礼制药-B07月22日主力净流出223.2万元 散户资金买入
市场透视 · 07-22
歌礼制药-B07月22日主力净流出223.2万元 散户资金买入
歌礼制药-B8月15日举行董事会会议考虑及批准中期业绩
格隆汇 · 07-21
歌礼制药-B8月15日举行董事会会议考虑及批准中期业绩
歌礼制药午后强势走强,ASC47临床前研究表明具备减脂增肌降体重潜力
智通财经 · 07-18
歌礼制药午后强势走强,ASC47临床前研究表明具备减脂增肌降体重潜力
欧康维视生物-B盘中异动 下午盘股价大涨5.53%
市场透视 · 07-17
欧康维视生物-B盘中异动 下午盘股价大涨5.53%
港股异动 | 歌礼制药-B(01672)早盘涨超11% ASC47联合司美格鲁肽治疗肥胖症的美国临床研究完成受试者给药
智通财经 · 07-17
港股异动 | 歌礼制药-B(01672)早盘涨超11% ASC47联合司美格鲁肽治疗肥胖症的美国临床研究完成受试者给药
加载更多
公司概况
公司名称:
欧康维视生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。其主要产品包括OT-401(YUTIQ)、OT-1001(ZERVIATE)、OT-502(DEXYCU)、OT-301(NCX 470)、OT-101和OT-202等。该公司在中国境内开展业务。
发行价格:
--
{"stockData":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"欧康维视生物-B","latestPrice":9.39,"timestamp":1753690152005,"preClose":9.38,"halted":0,"volume":2767500,"delay":0,"floatShares":814000000,"shares":814000000,"eps":-0.4289756047099459,"marketStatus":"已收盘","change":0.01,"latestTime":"07-28 16:09:12","open":9.4,"high":9.5,"low":9.15,"amount":25834670,"amplitude":0.037313,"askPrice":9.4,"askSize":500,"bidPrice":9.39,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-0.4289756047099459,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753752600000},"marketStatusCode":5,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":9.38,"openAndCloseTimeList":[[1753666200000,1753675200000],[1753678800000,1753689600000]],"volumeRatio":0.542967,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01477","defaultTab":"news","newsList":[{"id":"2554720181","title":"上海医药(02607.HK):硫酸沙丁胺醇注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2554720181","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554720181?lang=zh_cn&edition=full","pubTime":"2025-07-28 18:06","pubTimestamp":1753697213,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0188","BK0183","BK1574","BK0184","BK0175","BK0209","BK1197","BK0097","BK0028","BK0020","01477","BK1191","BK0012","601607","BK0196","BK0099","BK0187","02607"],"gpt_icon":0},{"id":"2554092725","title":"歌礼制药-B盘中异动 下午盘股价大涨5.04%报11.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554092725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554092725?lang=zh_cn&edition=full","pubTime":"2025-07-28 15:16","pubTimestamp":1753687009,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘15时16分,歌礼制药-B股票出现异动,股价快速上涨5.04%。截至发稿,该股报11.260港元/股,成交量181.6万股,换手率0.19%,振幅7.28%。资金方面,该股资金流入1063.67万港元,流出768.908万港元。歌礼制药-B股票所在的生物技术行业中,整体涨幅为2.62%。其相关个股中,北海康成-B、复宏汉霖、方达控股涨幅较大,振幅较大的相关个股有北海康成-B、方达控股、创胜集团-B,振幅分别为20.51%、18.18%、14.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728151649a6c568f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728151649a6c568f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1515","BK1161","BK1191","BK1574","01477"],"gpt_icon":0},{"id":"2554747987","title":"港股异动 | 中生制药(01177)再涨超6% 机构称BD交易有望成为公司的经常性收入和利润来源","url":"https://stock-news.laohu8.com/highlight/detail?id=2554747987","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554747987?lang=zh_cn&edition=full","pubTime":"2025-07-28 11:26","pubTimestamp":1753673211,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中生制药再涨超6%,年内累计涨幅已近130%。据悉,中生制药7月15日宣布,以超5亿美元净额收购礼新医药近95.09%股份。中银国际发表研报称,考虑到礼新医药多项资产在全球市场拥有一定潜力,预期中生制药有1至2宗授权交易变得更具可见性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","IE00BZ08YR35.GBP","BK1521","IE00BZ08YS42.EUR","01177","BK1191","BK1589","IE00BZ08YT58.USD","BK1574","01477"],"gpt_icon":0},{"id":"2554749270","title":"和铂医药:预计上半年净利润6800万美元-7400万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554749270","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554749270?lang=zh_cn&edition=full","pubTime":"2025-07-28 08:50","pubTimestamp":1753663806,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","01477","BK1161","02142","BK1191","BK1583"],"gpt_icon":0},{"id":"2554698749","title":"歌礼制药-B(01672):小分子GLP-1R激动剂ASC30每月一次皮下储库型制剂的美国12周IIa期研究完成首批肥胖或超重受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2554698749","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554698749?lang=zh_cn&edition=full","pubTime":"2025-07-28 08:17","pubTimestamp":1753661877,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B 发布公告,小分子GLP-1受体激动剂 ASC30每月一次皮下储库型制剂治疗肥胖症的美国12周IIa期研究已完成首批受试者给药,受试者为肥胖人群或伴有至少一种体重相关合并症的超重人群。预计将于2026年第一季度获得顶线数据。ASC30是一款正在临床研究中的小分子GLP-1R偏向激动剂,具有独特和差异化性质,使得同一小分子同时适用于口服片剂和皮下注射给药成为可能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK4144","GLP","BK1161","01477","BK1191","BK4590","01672"],"gpt_icon":0},{"id":"2554715664","title":"同道堂制药取得用于中药生产的结晶反应釜专利,可缩短重结晶时间","url":"https://stock-news.laohu8.com/highlight/detail?id=2554715664","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554715664?lang=zh_cn&edition=full","pubTime":"2025-07-26 14:31","pubTimestamp":1753511510,"startTime":"0","endTime":"0","summary":"金融界2025年7月26日消息,国家知识产权局信息显示,四川成都同道堂制药有限责任公司取得一项名为“用于中药生产的结晶反应釜”的专利,授权公告号CN223144728U,申请日期为2024年10月。专利摘要显示,本实用新型公开了用于中药生产的结晶反应釜,包括支撑架、冷凝组件、釜体与盖体,所述冷凝组件包括冷凝器、出水管与进水管。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/26143152003929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2554756144","title":"港股异动 | 和铂医药-B(02142)午后涨超8% 近期与大冢制药达成BD交易 公司上半年BD总额超66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554756144","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554756144?lang=zh_cn&edition=full","pubTime":"2025-07-25 13:59","pubTimestamp":1753423161,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和铂医药-B午后涨超8%,截至发稿,涨8.89%,报9.68港元,成交额1.58亿港元。消息面上,今年6月,和铂医药宣布,公司与大冢制药达成全球战略合作。大冢制药将以4700万美元的首付款和里程碑付款获得在全球范围内开发、生产和商业化HBM7020的独家许可,其他额外付款高达6.23亿美元。2025年上半年,和铂达成多笔BD交易,包括TSLP单抗9.7亿美元、阿斯利康45.75亿美元、CRH疗法3.95亿美元及TCE双抗6.7亿美元,BD总金额超过66亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01477","BK1583","02142","BK1161","BK1191"],"gpt_icon":0},{"id":"2554327677","title":"港股异动 | 中生制药(01177.HK)再涨超4% 附属礼新医药LM-350获得美国FDA的IND批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2554327677","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554327677?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:59","pubTimestamp":1753408758,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","01477","01177","09939","BK1521","159938","BK1191","BK1589","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1161","IE00BZ08YS42.EUR","BK1515"],"gpt_icon":0},{"id":"2553208431","title":"欧康维视生物-B07月24日主力净流入372.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2553208431","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553208431?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344947,"startTime":"0","endTime":"0","summary":"07月24日, 欧康维视生物-B股价涨0.76%,报收9.28元,成交金额4303.7万元,换手率0.57%,振幅3.91%,量比0.81。欧康维视生物-B今日主力资金净流入372.0万元,上一交易日主力净流出533.2万元。该股近5个交易日下跌6.17%,主力资金累计净流出101.7万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出879.0万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165938a460ed49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165938a460ed49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2553272789","title":"制药企业将被转卖给大基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2553272789","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553272789?lang=zh_cn&edition=full","pubTime":"2025-07-24 15:25","pubTimestamp":1753341900,"startTime":"0","endTime":"0","summary":"制药巨头Gland Pharma可能被以214亿转卖。该公司由PVN Raju创立,是复星医药控股子公司,业务覆盖全球60国,近年还布局了复杂注射制剂及生物药CDMO业务。尽管复星医药逐渐减持Gland Pharma股份,但依然保持控股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724155724971b8cc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724155724971b8cc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","BK1191","01477","BK1574","02196","600196"],"gpt_icon":0},{"id":"2553027521","title":"港股康希诺拉升涨近14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553027521","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553027521?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:32","pubTimestamp":1753335135,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1794554557.SGD","07226","BK4614","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","HSCEI","01672","LU0348784397.USD","688185","159837","09926","BK1515","LU0348783233.USD","HSTECH","LU1720050803.USD","LU0417516571.SGD","01477","BK0239","YANG","BK1191","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2553202493","title":"歌礼制药-B大涨5.32% 近日完成ASC47与司美格鲁肽联合使用的28例肥胖受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2553202493","media":"港美通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553202493?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:21","pubTimestamp":1753334484,"startTime":"0","endTime":"0","summary":"7月24日13:14,歌礼制药-B(01672)上涨5.32%,该股报11.080港元,最高报11.080港元,最低报10.380港元,成交量181.49万股,成交额1931.00万港元。消息面上,歌礼制药-B近日发布公告,宣布其在美国开展的联合用药研究已完成所有28例肥胖受试者的给药。这项研究旨在评估超长效皮下注射小分子THRβ激动剂ASC47单次给药与司美格鲁肽联合使用的安全性、耐受性以及初步疗效。该临床试验于2025年5月开始入组,所有受试者在两个月内快速完成入组。预期将在2025年第四季度获得顶线数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072418392994b816ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072418392994b816ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1515","BK1574","BK1191","01477","BK1161"],"gpt_icon":0},{"id":"2553926452","title":"汉邦科技:公司作为制药装备生产提供商促进创新药发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2553926452","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553926452?lang=zh_cn&edition=full","pubTime":"2025-07-23 15:33","pubTimestamp":1753256010,"startTime":"0","endTime":"0","summary":"随着创新药物的研发加速,纯化环节在药物生产过程中的重要性愈发显著,市场对于高质量制药装备以及创新药物生产解决方案的需求将持续攀升。公司作为制药装备生产提供商,将紧跟创新生物药及化学药物研发生产的发展步伐,积极满足相关需求,努力为创新药药物的发展贡献更多力量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300021177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688755","BK0251","06978","BK1191","01477","BK1574","159992","BK1161"],"gpt_icon":0},{"id":"2553258925","title":"莱美药业股价微涨0.20% 化学制药企业研发管线引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2553258925","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553258925?lang=zh_cn&edition=full","pubTime":"2025-07-22 19:26","pubTimestamp":1753183612,"startTime":"0","endTime":"0","summary":"莱美药业7月22日收盘报4.91元,较前一交易日上涨0.01元。盘中最高触及5.15元,最低下探4.80元,全天成交118万手,成交金额达5.87亿元。该公司属于化学制药行业,主营业务涵盖抗感染类、特色专科用药等药品的研发、生产和销售。作为重庆地区医药企业,莱美药业在创新药领域有所布局,涉及幽门螺杆菌治疗和辅助生殖等相关产品研发。7月22日早盘时段,莱美药业曾出现快速反弹,在9点35分前的5分钟内涨幅超过2%。当日主力资金呈现净流出状态,净流出金额为3220.67万元。风险提示:股市有风险,投资需谨慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/22192651894654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0070","01477","BK0239","300006","BK1191","BK1574"],"gpt_icon":0},{"id":"2553531230","title":"7月22日AI制药(医疗)下跌0.58%,板块个股嘉和美康、润达医疗跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2553531230","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553531230?lang=zh_cn&edition=full","pubTime":"2025-07-22 18:55","pubTimestamp":1753181756,"startTime":"0","endTime":"0","summary":"7月22日,截至收盘,AI制药(医疗)概念下跌0.58%,板块资金流出17542.35万。上涨个股家数11个,下跌个股家数28个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/22185551892385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603108","BK1574","BK0231","688246","159891","BK1191","BK0250","01477"],"gpt_icon":0},{"id":"2553234029","title":"歌礼制药-B07月22日主力净流出223.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2553234029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553234029?lang=zh_cn&edition=full","pubTime":"2025-07-22 16:16","pubTimestamp":1753172165,"startTime":"0","endTime":"0","summary":"07月22日, 歌礼制药-B股价跌2.74%,报收11.38元,成交金额6528.6万元,换手率0.58%,振幅6.15%,量比0.74。歌礼制药-B今日主力资金净流出223.2万元,上一交易日主力净流入294.1万元。该股近5个交易日上涨22.16%,主力资金累计净流入3532.4万元;近20日主力资金累计净流入2754.8万元,其中净流入天数为12日。该股主力净额占比0.02%,港股市场排名2395/2671。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170950a45beb7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722170950a45beb7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01672","BK1574","BK1161","01477"],"gpt_icon":0},{"id":"2553471362","title":"歌礼制药-B8月15日举行董事会会议考虑及批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2553471362","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553471362?lang=zh_cn&edition=full","pubTime":"2025-07-21 16:41","pubTimestamp":1753087310,"startTime":"0","endTime":"0","summary":"格隆汇7月21日丨歌礼制药-B(01672.HK)宣布,董事会会议将于2025年8月15日(星期五)举行,藉以(其中包括)考虑及批准公司及其附属公司截至2025年6月30日止六个月的中期业绩及其发布,并考虑建议派发中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072116422097ae6ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072116422097ae6ad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01477","01672","BK1515","BK1191"],"gpt_icon":0},{"id":"2552457172","title":"歌礼制药午后强势走强,ASC47临床前研究表明具备减脂增肌降体重潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2552457172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552457172?lang=zh_cn&edition=full","pubTime":"2025-07-18 14:42","pubTimestamp":1752820928,"startTime":"0","endTime":"0","summary":"中信建投指出,ASC47临床前研究具备减脂增肌降体重效果,潜力十足。公司的ASC47临床前研究表明,在联合司美格鲁肽给药小鼠时,相较于司美格鲁肽组,联合组展示了更高的体重下降趋势。整体看,ASC47在临床前的动物模型中展现出了初步的减脂增肌和降体重能力,后续人体研究结果可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071814422997aac3e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071814422997aac3e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1191","BK1574","01672","01477"],"gpt_icon":0},{"id":"2552810680","title":"欧康维视生物-B盘中异动 下午盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552810680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552810680?lang=zh_cn&edition=full","pubTime":"2025-07-17 14:23","pubTimestamp":1752733403,"startTime":"0","endTime":"0","summary":"2025年07月17日下午盘14时23分,欧康维视生物-B股票出现波动,股价快速拉升5.53%。截至发稿,该股报10.120港元/股,成交量530.892万股,换手率0.65%,振幅6.99%。欧康维视生物-B股票所在的生物技术行业中,整体涨幅为7.23%。欧康维视生物-B公司简介:欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071714232397a96014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071714232397a96014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2552174524","title":"港股异动 | 歌礼制药-B(01672)早盘涨超11% ASC47联合司美格鲁肽治疗肥胖症的美国临床研究完成受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174524?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:36","pubTimestamp":1752716162,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,歌礼制药-B早盘涨超11%,截至发稿,涨11.6%,报10.2港元,成交额2046.21万港元。消息面上,歌礼制药发布公告,宣布其在美国开展的联合用药研究已完成所有28例肥胖受试者的给药。这项研究旨在评估超长效皮下注射小分子THRβ激动剂ASC47单次给药与司美格鲁肽联合使用的安全性、耐受性以及初步疗效。中信建投此前表示,歌礼制药的ASC30和ASC47两款药物亮相ADA大会,产品后续前景值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01477","BK1515","BK1574","01672","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocumension.com","stockEarnings":[{"period":"1week","weight":-0.0592},{"period":"1month","weight":-0.1184},{"period":"3month","weight":0.6993},{"period":"6month","weight":1.2227},{"period":"1year","weight":0.4042},{"period":"ytd","weight":1.0844}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0373},{"period":"3month","weight":0.155},{"period":"6month","weight":0.2652},{"period":"1year","weight":0.493},{"period":"ytd","weight":0.2656}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"欧康维视生物是一家主要从事眼科疗法发现、开发及商业化业务的中国控股公司。其主要产品包括OT-401(YUTIQ)、OT-1001(ZERVIATE)、OT-502(DEXYCU)、OT-301(NCX 470)、OT-101和OT-202等。该公司在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.116968},{"month":2,"riseRate":0.4,"avgChangeRate":-0.049128},{"month":3,"riseRate":0.6,"avgChangeRate":0.058111},{"month":4,"riseRate":0.4,"avgChangeRate":0.017956},{"month":5,"riseRate":0.6,"avgChangeRate":0.137077},{"month":6,"riseRate":0.8,"avgChangeRate":0.129408},{"month":7,"riseRate":0.4,"avgChangeRate":-0.045098},{"month":8,"riseRate":0.4,"avgChangeRate":-0.050881},{"month":9,"riseRate":0.2,"avgChangeRate":-0.087999},{"month":10,"riseRate":0.2,"avgChangeRate":-0.144034},{"month":11,"riseRate":0.4,"avgChangeRate":0.008996},{"month":12,"riseRate":0.6,"avgChangeRate":0.089218}],"exchange":"SEHK","name":"欧康维视生物-B","nameEN":"OCUMENSION-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧康维视生物-B,01477,欧康维视生物-B股票,欧康维视生物-B股票老虎,欧康维视生物-B股票老虎国际,欧康维视生物-B行情,欧康维视生物-B股票行情,欧康维视生物-B股价,欧康维视生物-B股市,欧康维视生物-B股票价格,欧康维视生物-B股票交易,欧康维视生物-B股票购买,欧康维视生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}